Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company whose news flow centers on deployments, partnerships, regulatory developments, and capital markets activity related to its SteraMist systems and Binary Ionization Technology (BIT) platform. The company’s announcements highlight how its ionized Hydrogen Peroxide (iHP) technology is integrated into high-stakes environments where contamination control and infection prevention are essential.
Recent news releases describe multi-stage SteraMist iHP implementations at cell and gene therapy manufacturing sites, integration of SteraMist Integrated Systems into critical pharmaceutical manufacturing infrastructure, and installation of a SteraMist Hybrid System in a research university facility for reusable medical product sterilization. TOMI also reports on its role in life sciences and medical device sectors through a custom integration pipeline involving SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, supported by partnerships with enclosure manufacturers.
Investors and industry observers following TOMZ news will find updates on TOMI’s outreach to cruise lines for advanced maritime decontamination, participation in sector events such as the American Association for Laboratory Animal Science National Meeting, and expansion into animal research and academic markets. The company’s releases also cover financial milestones, including quarterly results, pipeline updates, universal shelf registration filings, equity line of credit arrangements, and Nasdaq listing compliance notices.
This news page aggregates these disclosures, offering a centralized view of TOMI’s commercial projects, strategic relationships, regulatory and financing steps, and sector-focused initiatives involving its SteraMist and BIT-based disinfection technology.
TOMI Environmental Solutions (NASDAQ: TOMZ) reported 2025 revenue of $5.64M versus $7.74M in 2024, with gross margin near 55% and a net loss of $3.75M (‑$0.19 per share). Cash was $88,000 and working capital about $1.0M. Backlog rose to $1.8M; the company completed a $535k convertible note and established a $20M equity line (first draw $94,130).
Management highlighted international expansion, R&D investments, signed integration projects (~$3M), and larger opportunity books of $16M (integration) and $20M (SteraMist iHP).
TOMI Environmental Solutions (NASDAQ: TOMZ) will report fourth quarter results for the period ended December 31, 2025, after market close on Tuesday, March 31, 2026, and will host a conference call at 4:30 p.m. ET that day.
Investors may join by phone (domestic: (888) 506-0062; international: (973) 528-0011) using access code 903042, or listen via live webcast on the company’s Investor Relations website. Teleconference replay runs through April 7, 2026, and a webcast replay will be available for at least 90 days.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced that its Binary Ionization Technology (BIT) Solution received formal authorization from the Dutch regulatory authority ctgb on March 24, 2026 as a PT2 disinfectant for professional indoor use using SteraMist room fogging and surface spraying equipment.
The approval, granted under the EU Biocidal Products Regulation (BPR), is TOMI's first product authorization in an EU member state and may support streamlined mutual recognition across twelve named EU countries. Netherlands partner Ster-Pharma (since 2019) is positioned to commercialize products quickly.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a commercial deployment of SteraMist iHP at a major Mexican dairy facility on March 24, 2026. DisinfectCare conducted efficacy studies showing significant reductions in key pathogens and improved cheese preservation. An open purchase order covers seven pallets, about $128,000 USD of BIT Solution annually, with the first pallet shipping this month. DisinfectCare will use the SteraMist Environment System daily and the manufacturer may integrate SteraMist Hybrid Systems across additional sites to scale facility-wide disinfection.
The announcement cites projected growth in Mexico's food processing market and emphasizes expanded deployment and ongoing service adoption.
TOMI Environmental Solutions (NASDAQ: TOMZ) said it is expanding into the food safety sector using SteraMist ionized Hydrogen Peroxide (iHP) technology to cut sanitation validation costs by up to 95%. A CPG partner reduced external testing and materials from about $100,000 to $5,000 annually.
The company reports the partner cut environmental sampling to once per quarter after implementation and has deployed SteraMist to multiple partner facilities, highlighting portability for deep machinery disinfection and potential scalability across food manufacturing sites.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced expansion across Canada on March 16, 2026, driven by multiple SteraMist iHP technology placements in leading hospital systems and Canada’s largest health research organization.
The company reported integrations in a special pathogens unit, deployments at a Nova Scotia trauma center and a research university, and increased Canadian distributor inventory to support direct-to-customer sales and ongoing competitive bids for the fiscal year.
TOMI Environmental Solutions (NASDAQ: TOMZ) appointed Total Clean Air as its Preferred European Partner for SteraMist iHP, making TCA the primary provider for sales, service, and technical support across the UK and EU. The agreement adds in-region validation, consignment stock, a UK showroom, and a dedicated workshop to support GMP Annex 1 compliance and surge demand in life sciences.
Market context includes a UK infection control market projected to exceed $6 billion by 2031 and a UK sterility testing market forecast at a 14% CAGR through 2035.
TOMI Environmental Solutions (NASDAQ: TOMZ) received Health and Safety Executive authorizations GB-2016-1042 (Great Britain) and NI-2026-1350 (Northern Ireland) on Feb. 23, 2026, allowing its Binary Ionization Technology (BIT) and SteraMist iHP products for registered biocidal uses.
Approvals cover room fogging and handheld surface spray on dry, pre-cleaned, hard, non-porous surfaces across healthcare, industrial, hospitality, and institutional sectors; specific EN and AOAC efficacy contact times are listed for bactericidal, yeasticidal, and virucidal claims.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced on Jan 20, 2026 the sale of a Custom Engineered System (CES) in the United Kingdom to an international pharmaceutical manufacturer. The CES integrates SteraMist iHP into Total Clean Air's modular cleanroom platform, the first deployment of iHP within that architecture. The integration is described as regulator-ready for MHRA and EMA expectations and intended to provide a repeatable, scalable decontamination model across pharmaceutical cleanrooms.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced the purchase and installation of a SteraMist Hybrid System in a new sterilization facility at a private East Coast research university on January 6, 2026.
The system will be used for repeatable, high‑level decontamination of reusable medical equipment distributed to patient homes and is intended to maintain isolation and minimize manual intervention during sterilization phases. This unit is the second SteraMist Hybrid sale within a $13 million automated installation pipeline that includes Custom Engineered Systems and the SteraMist Integrated System platform.